JP2015505540A5 - - Google Patents

Download PDF

Info

Publication number
JP2015505540A5
JP2015505540A5 JP2014553530A JP2014553530A JP2015505540A5 JP 2015505540 A5 JP2015505540 A5 JP 2015505540A5 JP 2014553530 A JP2014553530 A JP 2014553530A JP 2014553530 A JP2014553530 A JP 2014553530A JP 2015505540 A5 JP2015505540 A5 JP 2015505540A5
Authority
JP
Japan
Prior art keywords
composition
infection
subject
sandalwood oil
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014553530A
Other languages
English (en)
Japanese (ja)
Other versions
JP6134739B2 (ja
JP2015505540A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/022743 external-priority patent/WO2013112582A1/en
Publication of JP2015505540A publication Critical patent/JP2015505540A/ja
Publication of JP2015505540A5 publication Critical patent/JP2015505540A5/ja
Application granted granted Critical
Publication of JP6134739B2 publication Critical patent/JP6134739B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014553530A 2012-01-23 2013-01-23 ビャクダン油およびクロストリジウム感染症に関連するその使用 Expired - Fee Related JP6134739B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261589601P 2012-01-23 2012-01-23
US61/589,601 2012-01-23
PCT/US2013/022743 WO2013112582A1 (en) 2012-01-23 2013-01-23 Sandalwood oil and its uses related to clostridium infections

Publications (3)

Publication Number Publication Date
JP2015505540A JP2015505540A (ja) 2015-02-23
JP2015505540A5 true JP2015505540A5 (https=) 2015-12-24
JP6134739B2 JP6134739B2 (ja) 2017-05-24

Family

ID=48873861

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014553530A Expired - Fee Related JP6134739B2 (ja) 2012-01-23 2013-01-23 ビャクダン油およびクロストリジウム感染症に関連するその使用

Country Status (6)

Country Link
US (2) US9579354B2 (https=)
EP (1) EP2806882B1 (https=)
JP (1) JP6134739B2 (https=)
AU (1) AU2013212264B2 (https=)
CA (1) CA2862483A1 (https=)
WO (1) WO2013112582A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140154342A1 (en) * 2011-07-28 2014-06-05 Santalis Pharmaceuticals Inc. Sandalwood oil and its uses related to skin disorders
US9861670B2 (en) 2013-03-13 2018-01-09 Santalis Healthcare Corporation Stabilized cream formulations comprising sandalwood oil
JP2018529752A (ja) 2015-10-07 2018-10-11 サンタリス ファーマシューティカルズ インコーポレイテッド サンダルウッド油及び口腔粘膜炎に関連するその用途
BR112019018861A2 (pt) 2017-03-08 2023-10-10 Hope Medical Entpr Inc Dba Hope Pharmaceuticals Uso de nitrito de sódio, método para manter os níveis fisiológicos de nitrito, prevenir enfarte do miocárdio, prevenir morte súbita cardíaca, prevenir acidente vascular cerebral, doenças cardiovasculares, pressão alta, solução aquosa
IL268883B (en) 2017-03-08 2022-09-01 Hope Medical Entpr Inc Dba Hope Pharmaceuticals Intradialytic use of sodium thiosulfate
EP3836947A4 (en) * 2018-08-17 2022-04-20 Universidad Andres Bello METHOD AND PHARMACOLOGICAL COMPOSITION FOR THE PREVENTION OF RECURRING INFECTIONS CAUSED BY CLOSTRIDIUM DIFFICILE
CN111544353A (zh) * 2020-05-21 2020-08-18 天津芸熙生物技术有限公司 一种抑菌口腔喷雾剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0779819A1 (en) 1994-09-06 1997-06-25 Galagen Inc. Therapeutic treatment of clostridium difficile associated diseases
GB0414886D0 (en) 2004-07-02 2004-08-04 Neutec Pharma Plc Treatment of bacterial infections
JP2006124296A (ja) 2004-10-27 2006-05-18 Tomihiko Higuchi ヘリコバクター・ピロリ菌感染症治療のための医薬組成物
US7858126B2 (en) * 2006-08-31 2010-12-28 Trinity Laboratories Inc. Derivatives of sandalwood oil and santalols for treating cold sores and herpes
WO2009014781A2 (en) 2007-05-02 2009-01-29 Nucryst Pharmaceuticals Corp. Metal-containing materials for treatment of bacterial conditions
WO2011109411A2 (en) 2010-03-01 2011-09-09 Santalis Pharmaceuticals Inc. Sandalwood oil and its uses
US8986697B2 (en) 2010-04-15 2015-03-24 Progenics Pharmaceuticals, Inc. Antibodies for the treatment of Clostridium difficile-associated infection and disease
MX2012013372A (es) 2010-05-18 2013-05-01 Optimer Pharmaceuticals Inc Metodos para tratar infecciones bacterianas recurrentes.
EP2613802A4 (en) * 2010-09-10 2014-03-26 Viropharma Inc ENVIRONMENTAL CLOSTRIDAL BACTERIOTHERAPY AND ASSOCIATED FORMULATIONS AND METHODS OF MAKING AND USING SAME

Similar Documents

Publication Publication Date Title
JP2015505540A5 (https=)
Hade et al. An effective peptide-based platform for efficient exosomal loading and cellular delivery of a microRNA
Giannelli et al. The rationale for targeting TGF‐β in chronic liver diseases
HRP20200925T1 (hr) Pripravak za liječenje dijabetesa koji uključuje analog oksintomodulina
NZ731657A (en) Composition for treating hyperlipidemia comprising oxyntomodulin derivative
JP2018503668A5 (https=)
DOP2017000177A (es) Nuevos anticuerpos anti-cd38 para el tratamiento del cáncer
MX339469B (es) Agentes inductores de apotosis para el tratamiento de cancer y enfermedades inmunes y autoinmunes.
JP2021517156A5 (https=)
JP2013067645A5 (https=)
JP2014512390A5 (https=)
GB2496794A (en) Combination pharmaceutical composition and methods of treating and methods of treating functional diseases or conditions of gastrointestinal tract
JP2018510132A5 (https=)
BR112012029975A2 (pt) peptídeo como medicamento, em particular para o tratamento do câncer.
JP2016502515A5 (https=)
EA201400963A1 (ru) Фармацевтический препарат, содержащий производное дигидрохиназолина с противовирусной активностью
JOP20240254A1 (ar) عمليات ومركب وسيط لتحضير واسع النطاق لـ 2، 4، 6-تراي فلورو-n--بنزاميد هيمي سكسينات، وتحضير 2، 4، 6-تراي فلورو-n--بنزاميد أسيتات
JP2013503165A5 (https=)
JP2017524003A5 (https=)
Garcia-Olmo et al. Cumulative evidence that mesenchymal stem cells promote healing of perianal fistulas of patients with Crohn's Disease–Going From Bench to Bedside
JP2017503014A5 (https=)
MX388251B (es) Nuevo anticuerpo que se una a tfpi y composicion que comprende el mismo.
Kosanović et al. Extracellular vesicles and renal fibrosis: an odyssey toward a new therapeutic approach
Durbin Dengue vascular leak syndrome: insights into potentially new treatment modalities
Thang et al. Novel polymer-based hydrogels of recent research in drug delivery for disease treatment related to SARS-CoV-2 virus